# Beam Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:42227a4d-f343-46c6-9316-7ff1310750f1 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/beam-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 28 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:54.212776+00:00 | | Last reviewed | 2026-10-17T04:45:54.212776+00:00 | ## Identity - Legal name: Beam Therapeutics Inc. - Display name: Beam Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T11:06:35.422443+00:00 | | Completeness | 0.409 | | Record Quality | 0.827 | | Directors | 10 | | Committees | 2 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Giuseppe Ciaramella: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-17. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:7 - John Evans: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-17. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:9 - John Maraganore: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-17. Committees: nominating and corporate governance committee (chair); science and technology committee (member). claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:10 - Mark Fishman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-17. Committees: nominating and corporate governance committee (member); science and technology committee (chair). claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:13 - Chirfi Guindo: Director (Class I). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:5 - Christi Shaw: Director (Class III). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:6 - Graham Cooper: Director (Class I). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:8 - John Maraganore, Ph.D.: Director (Class III). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:11 - Kathleen Walsh: Director (Class II). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:12 - Mark Fishman, M.D.: Lead Independent Director (Class II). Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:14 ## Committees - nominating and corporate governance committee (nominating_governance). Chair: John Maraganore. Members: John Maraganore (chair, current); Mark Fishman (member, current). committee_id=alpha:committee:beam-therapeutics-inc:nominating-and-corporate-governance-committee - science and technology committee (technology). Chair: Mark Fishman. Members: Mark Fishman (chair, current); John Maraganore (member, current). committee_id=alpha:committee:beam-therapeutics-inc:science-and-technology-committee ## Executive leadership - Amy Simon: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:15 - Christine Bellon: Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:17 - Giuseppe Ciaramella: President [PRESIDENT]. Status: current. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:19 - Amy Simon, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:16 - Christine Bellon, Ph.D.: Chief Legal Officer and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:18 - Giuseppe Ciaramella, Ph.D.: President [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:20 - John Evans: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:21 - Sravan K. Emany: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:22 ## Governance events - DIRECTOR_APPOINTED: Giuseppe Ciaramella seat on Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:ggx76mltdyxk - DIRECTOR_APPOINTED: John Evans seat on Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:8thmjs3yqb7i - DIRECTOR_APPOINTED: John Maraganore seat on Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:1xpan68efyzfy - DIRECTOR_APPOINTED: Mark Fishman seat on Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:2p0qdz1r4e69x - EXECUTIVE_APPOINTED: Amy Simon executive of Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:18iunz4uykx58 - GC_CHANGED: Christine Bellon executive of Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:1w5xk9210ye6v2 - EXECUTIVE_APPOINTED: Giuseppe Ciaramella executive of Beam Therapeutics Inc., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-17T04:45:54.212776+00:00. event_id=alpha:event:transition:12cy0a1o004qk ## Scoped resources - `alpha://company/beam-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record - `alpha://company/beam-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=identity - `alpha://company/beam-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/beam-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=board - `alpha://company/beam-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=committees - `alpha://company/beam-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=leadership - `alpha://company/beam-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=ownership - `alpha://company/beam-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=financials - `alpha://company/beam-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/beam-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=compensation - `alpha://company/beam-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=governance - `alpha://company/beam-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/beam-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=audit - `alpha://company/beam-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=legal - `alpha://company/beam-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=risk - `alpha://company/beam-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=cyber - `alpha://company/beam-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/beam-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=agents - `alpha://company/beam-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/beam-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=events - `alpha://company/beam-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=relationships - `alpha://company/beam-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=assessments - `alpha://company/beam-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:24: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:john-maraganore-beam","name":"John Maraganore"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:25: `{"kind":"committee_appointment","original_name":"nominating and corporate governance committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:mark-fishman-beam","name":"Mark Fishman"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:27: `{"kind":"committee_appointment","original_name":"science and technology committee","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:mark-fishman-beam","name":"Mark Fishman"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:28: `{"kind":"committee_appointment","original_name":"science and technology committee","category":"technology","role":"member","person":{"alpha_id":"alpha:person:john-maraganore-beam","name":"John Maraganore"},"source_id":"governance_people_committees"}` ## Leadership - Chirfi Guindo: Director (Class I). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Christi Shaw: Director (Class III). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Giuseppe Ciaramella: Director. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:7. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4062344f2d0be14209ff28b4f781ebb076dfacf54e6c6607b0ae90868fff0a47. - Graham Cooper: Director (Class I). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - John Evans: Director. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:9. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4062344f2d0be14209ff28b4f781ebb076dfacf54e6c6607b0ae90868fff0a47. - John Maraganore: Director. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:10. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4062344f2d0be14209ff28b4f781ebb076dfacf54e6c6607b0ae90868fff0a47. - John Maraganore, Ph.D.: Director (Class III). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Kathleen Walsh: Director (Class II). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Mark Fishman: Director. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:13. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4062344f2d0be14209ff28b4f781ebb076dfacf54e6c6607b0ae90868fff0a47. - Mark Fishman, M.D.: Lead Independent Director (Class II). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Amy Simon: Chief Medical Officer. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:15. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c6b3250985c402e9d7616007ef5a43f32b5080b7e3a09151927bd340b13105a9. - Amy Simon, M.D.: Chief Medical Officer. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Christine Bellon: Chief Legal Officer and Secretary. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:17. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:13b83f3948bc462f7429188b5a4f06a8c4b864053fed9f698faaefafdb94f28a. - Christine Bellon, Ph.D.: Chief Legal Officer and Secretary. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Giuseppe Ciaramella: President. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:19. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f09b8528ccd7bff3c2cc21aac9067002c82ddffac5cc2cdbef7f4240a752fb92. - Giuseppe Ciaramella, Ph.D.: President. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - John Evans: Chief Executive Officer. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. - Sravan K. Emany: Chief Financial Officer. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - nominating and corporate governance committee: Chair John Maraganore; Members John Maraganore (Chair); Mark Fishman. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542. - science and technology committee: Chair Mark Fishman; Members Mark Fishman (Chair); John Maraganore. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Beam Therapeutics Inc.. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c97989f9e8cdaa8fe154f0ae3c445ded4feaf69ade5cdc75a748116b39289c. ## Entity Status - Public listing published. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c97989f9e8cdaa8fe154f0ae3c445ded4feaf69ade5cdc75a748116b39289c. ## Published Fact - US. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c97989f9e8cdaa8fe154f0ae3c445ded4feaf69ade5cdc75a748116b39289c. ## Committee Appointment - John Maraganore: chair, nominating and corporate governance committee. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542. - Mark Fishman: member, nominating and corporate governance committee. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542. - Mark Fishman: chair, science and technology committee. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542. - John Maraganore: member, science and technology committee. Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542. ## Security Listing - BEAM (NASDAQ). Claim: alpha:claim:company:42227a4d-f343-46c6-9316-7ff1310750f1:security_listing:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:26c97989f9e8cdaa8fe154f0ae3c445ded4feaf69ade5cdc75a748116b39289c. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:26c97989f9e8cdaa8fe154f0ae3c445ded4feaf69ade5cdc75a748116b39289c: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/beam-therapeutics-inc). - alpha:projection-evidence:document:9c8ae5c948d88a8732a6c485603313349a50ed1d6445a672101cdd7bdeda8303: [SEC DEF 14A 0001193125-26-161512](https://www.sec.gov/Archives/edgar/data/1745999/000119312526161512/beam-20260417.htm). - alpha:projection-evidence:document:4062344f2d0be14209ff28b4f781ebb076dfacf54e6c6607b0ae90868fff0a47: [DEF 14A beam-20260417.htm](https://www.sec.gov/Archives/edgar/data/1745999/000119312526161512/beam-20260417.htm). - alpha:projection-evidence:document:c6b3250985c402e9d7616007ef5a43f32b5080b7e3a09151927bd340b13105a9: [BEAM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1745999/000119312526161512/beam-20260417.htm). - alpha:projection-evidence:document:13b83f3948bc462f7429188b5a4f06a8c4b864053fed9f698faaefafdb94f28a: [BEAM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1745999/000119312526161512/beam-20260417.htm). - alpha:projection-evidence:document:f09b8528ccd7bff3c2cc21aac9067002c82ddffac5cc2cdbef7f4240a752fb92: [BEAM DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1745999/000119312526161512/beam-20260417.htm). - alpha:projection-evidence:e17160661eadc8b02440e627df9803cbdf9ab00f682f4cbda3cb301b61c79542: [nominating and corporate governance committee](https://www.sec.gov/Archives/edgar/data/1745999/000119312526161512/beam-20260417.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/beam-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/beam-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/beam-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/beam-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T11:06:35.236153+00:00; recorded 2026-10-17T11:06:35.236153+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.